Komal Kamra
Publication Details
-
A randomized, controlled trial of aprotinin in neonates undergoing open-heart surgery.
Paediatr Anaesth. 2008; (9): 812-9
Neonates undergoing open-heart surgery are especially at risk for massive bleeding and pronounced inflammation. The efficacy of aprotinin, a serine protease inhibitor, at ameliorating these adverse effects of cardiopulmonary bypass has not been clearly demonstrated in neonates.
